{"id":"W2529788651","doi":"10.1186/s12895-016-0051-4","title":"Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial","year":2016,"lang":"en","type":"article","venue":"BMC Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":98,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Innovaderm (Canada); Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Janus kinase inhibitor; Medicine; Plaque psoriasis; Dermatology; Janus kinase; Randomized controlled trial; Psoriasis; Pharmacology; Clinical trial; Internal medicine; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00334701,0.002194494,0.002660279,0.0005826631,0.0004895119,0.001305901,0.0009856847,0.002342035,0.01105468],"category_scores_gemma":[0.002107941,0.0008080513,0.001783142,0.0005571069,0.000976663,0.001106515,0.000416154,0.002800902,0.001567945],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007138716,"about_ca_system_score_gemma":0.00159863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006838522,"about_ca_topic_score_gemma":0.001231013,"domain_scores_codex":[0.9990891,0.0004781582,0.00005274448,0.0001600586,0.0001017991,0.0001180279],"domain_scores_gemma":[0.9991274,0.0002270665,0.0002153097,0.00006911188,0.00008036479,0.0002806863],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.966198,0.01182848,0.000430904,0.0008132497,0.000604733,0.00004255442,0.00005017801,0.0002493593,0.003144691,0.000119342,0.00129981,0.01521882],"study_design_scores_gemma":[0.9671596,0.03111906,0.0005978079,0.00002485506,0.000166286,0.00002449951,0.00000788231,0.0001831293,0.0001564776,0.00006409118,0.0004909587,0.000005362334],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9554363,0.01110167,0.001891588,0.002021745,0.00111835,0.01953676,0.003709093,0.0003119785,0.00487249],"genre_scores_gemma":[0.9484229,0.008786866,0.004639912,0.003001587,0.00126814,0.02328763,0.003543774,0.0000662632,0.006983014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01105468,"threshold_uncertainty_score":0.03698164,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04656576236925047,"score_gpt":0.3201715320557242,"score_spread":0.2736057696864738,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}